P. Borchmann

Effect of IFN-alpha on normal human hematopoiesis: an immunohistochemical and morphometric study on trephine biopsy specimens.

J. Thiele, C. Wickenhauser, H. Schulze, 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS

M. Kersten, G. Salles, U. Jaeger, 2019, Hematological Oncology.

Expression of immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections and their relation to the recurrence rate of superficial bladder tumors.

U. Engelmann, J. Thiele, R. Vorreuther, 1999, Urologia internationalis.

[Monoclonal antibodies (MIB 1, PC 10, 486p and p53) as prognostic factors for recurrent urothelial carcinoma of the urinary bladder].

J. Thiele, R. Vorreuther, R. Hake, 1993, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

P. Riedell, U. Jaeger, M. Leung, 2019, Hematological Oncology.

LBA38 BNT211-01: A phase I trial to evaluate safety and efficacy of CLDN6 CAR T cells and CLDN6-encoding mRNA vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumours

C. Bokemeyer, A. Mackensen, Ö. Türeci, 2022, Annals of Oncology.

LBA1 BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+ advanced solid tumors

A. Mackensen, Ö. Türeci, J. Haanen, 2021, Annals of Oncology.

TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

F. Morschhauser, K. Ardeshna, K. Izutsu, 2023, Hematological Oncology.